News

Emerald Bioscience Reports that Superior Reduction of Intraocular Pressure of its Unique Nanoemulsion Formulation of THCVHS is Published in Peer-Reviewed Journal

Drug Delivery and Translational Research article highlights significantly better drug load and duration of activity of prodrug of THC compared...

Abpro Announces Initiation of Phase 2/3 Registrational Studies of its Neutralizing Antibody Therapeutic ABP 300 for the Treatment of COVID-19

ABP 300 is a novel human antibody therapy that has been shown to neutralize COVID-19 in preclinical in vivo studiesPivotal/Registrational studies will assess safety, tolerability,...

Ciox Health’s Digital EHR Connections Fueling Health Data Transformation and Easing Provider Administrative Burden  

- Integration with EMRs driving provider participation and adoption - Payers experiencing improved accuracy, velocity, and expanded functionality, employing assistances for...

World Health Organization and Out There Impact join forces to use the power of mobile to prevent the ongoing spread of COVID-19 as world awaits vaccine rollout

Global campaign looks to reach hundreds of millions of global citizens by early 2021, sharing reliable, accurate and engaging information,...

Allysta Pharmaceuticals, Inc. Announces Positive Preclinical Data in a NASH Model Demonstrating its Adiponectin Analogue ALY688 Reduces Liver Fat, Inflammation, and Fibrosis

BELLEVUE, WA / ACCESSWIRE / December 16, 2020 / Allysta Pharmaceuticals, Inc. ("Allysta") today announced results from a study of...

Intellipharmaceutics Announces Change in Venue for The Company’s Annual General Meeting Scheduled To Be Held on December 23, 2020

TORONTO, ON / ACCESSWIRE / December 15, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company...

error: Content is protected !!